Characterization of the c9orf72 GC-rich low complexity sequence in two cohorts of Italian and Turkish ALS cases

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Lucia CorradoSandra D'Alfonso

Abstract

Large expansions of a noncoding GGGGCC repeat in the C9orf72 gene are the main cause of amyotrophic lateral sclerosis (ALS). The GGGGCC repeat is contiguous with another GC-rich region. Recent studies reported a significantly higher frequency of insertions/deletions within the GC-rich region in patients carrying the GGGGCC expansion. A GTGGT motif comprised within the GC-rich region, which joins two 100% GC sequences, was frequently deleted, supporting the hypothesis that these deletions could make the region more prone to slippage and pathological expansion. To confirm this hypothesis, we sequenced the GC-rich region adjacent the GGGGCC repeat in ALS patients, 116 C9orf72 expansion carriers, 219 non-carriers, and 223 healthy controls, from Italian and Turkish cohorts. Deletions were significantly more frequent in C9orf72 expansion carriers (6%) compared to non-carrier ALS patients (0.46%, OR =14.00, 95% CI =1.71-306.59, p = 0.003), to controls (0%, OR =16.29, 95% CI =2.12-725.99, p = 4.86 × 10-4) and to the whole cohort of non-carriers (0.2%, OR =28.51, 95% CI =3.47-618.91, p = 9.58 × 10-5). Among expansion carriers, deletions with or without the GTGGT motif were equally distributed (4 vs. 3). The frequency of insertions was n...Continue Reading

References

Jul 7, 2012·Neurobiology of Aging·Antonia RattiUNKNOWN SLAGEN Consortium
Nov 1, 2012·Human Mutation·Julie van der ZeeUNKNOWN European Early-Onset Dementia Consortium
Feb 6, 2014·Acta Neuropathologica·Hannah A PlinerBryan J Traynor
Apr 4, 2015·Journal of Neurology, Neurosurgery, and Psychiatry·Julie S SnowdenDavid M Mann
Jun 12, 2016·Molecular and Cellular Probes·Elaine M ClearyJon P Warner
Jan 15, 2017·Journal of Medical Genetics·Ai-Ling JiWen-Juan Huang
Jul 13, 2017·The New England Journal of Medicine·Robert H Brown, Ammar Al-Chalabi

❮ Previous
Next ❯

Citations

Aug 13, 2021·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Antonia RattiVincenzo Silani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.